Globus Medical (GMED) - Net Assets

Latest as of December 2025: $4.57 Billion USD

Based on the latest financial reports, Globus Medical (GMED) has net assets worth $4.57 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.30 Billion) and total liabilities ($729.51 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GMED asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$4.57 Billion
% of Total Assets	86.24%
Annual Growth Rate	22.12%
5-Year Change	162.62%
10-Year Change	449.62%
Growth Volatility	26.01

Globus Medical - Net Assets Trend (2010–2025)

This chart illustrates how Globus Medical's net assets have evolved over time, based on quarterly financial data. Also explore Globus Medical assets under control for the complete picture of this company's asset base.

Annual Net Assets for Globus Medical (2010–2025)

The table below shows the annual net assets of Globus Medical from 2010 to 2025. For live valuation and market cap data, see Globus Medical (GMED) market capitalisation.

Year	Net Assets	Change
2025-12-31	$4.57 Billion	+9.48%
2024-12-31	$4.18 Billion	+4.49%
2023-12-31	$4.00 Billion	+116.53%
2022-12-31	$1.85 Billion	+6.03%
2021-12-31	$1.74 Billion	+15.61%
2020-12-31	$1.51 Billion	+7.40%
2019-12-31	$1.40 Billion	+18.30%
2018-12-31	$1.19 Billion	+22.50%
2017-12-31	$967.78 Million	+16.31%
2016-12-31	$832.08 Million	+16.32%
2015-12-31	$715.32 Million	+22.18%
2014-12-31	$585.45 Million	+23.94%
2013-12-31	$472.36 Million	+22.21%
2012-12-31	$386.50 Million	+36.83%
2011-12-31	$282.48 Million	+23.79%
2010-12-31	$228.19 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Globus Medical's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1000.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	$1.39 Billion	30.35%
Common Stock	$135.00K	0.00%
Other Comprehensive Income	$15.35 Million	0.34%
Other Components	$3.17 Billion	69.31%
Total Equity	$4.57 Billion	100.00%

Globus Medical Competitors by Market Cap

The table below lists competitors of Globus Medical ranked by their market capitalization.

Company	Market Cap
Bajaj Holdings & Investment Limited NSE:BAJAJHLDNG	$12.36 Billion
Julius Baer Gruppe AG SW:BAER	$12.36 Billion
Anhui Conch Cement Co Ltd SHG:600585	$12.37 Billion
GD Power Development Co Ltd SHG:600795	$12.37 Billion
Kuang Chi Technologies Co Ltd SHE:002625	$12.35 Billion
Bollore SA PA:BOL	$12.34 Billion
Xpeng Inc NYSE:XPEV	$12.34 Billion
Var Energi ASA OL:VAR	$12.33 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Globus Medical's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 4,177,333,000 to 4,573,250,000, a change of 395,917,000 (9.5%).
Net income of 537,900,000 contributed positively to equity growth.
Share repurchases of 300,451,000 reduced equity.
Other comprehensive income increased equity by 22,207,000.
Other factors increased equity by 136,261,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	$537.90 Million	+11.76%
Share Repurchases	$300.45 Million	-6.57%
Other Comprehensive Income	$22.21 Million	+0.49%
Other Changes	$136.26 Million	+2.98%
Total Change	$-	9.48%

Book Value vs Market Value Analysis

This analysis compares Globus Medical's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.74x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 30.20x to 2.74x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	$3.02	$91.34	x
2011-12-31	$3.74	$91.34	x
2012-12-31	$4.19	$91.34	x
2013-12-31	$5.01	$91.34	x
2014-12-31	$6.13	$91.34	x
2015-12-31	$7.45	$91.34	x
2016-12-31	$8.63	$91.34	x
2017-12-31	$9.89	$91.34	x
2018-12-31	$11.70	$91.34	x
2019-12-31	$13.75	$91.34	x
2020-12-31	$14.92	$91.34	x
2021-12-31	$16.81	$91.34	x
2022-12-31	$17.99	$91.34	x
2023-12-31	$34.88	$91.34	x
2024-12-31	$30.30	$91.34	x
2025-12-31	$33.33	$91.34	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Globus Medical utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 11.76%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 18.30%
• Asset Turnover: 0.55x
• Equity Multiplier: 1.16x
Recent ROE (11.76%) is below the historical average (12.59%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	23.86%	18.90%	1.08x	1.17x	$31.64 Million
2011	21.52%	18.34%	1.01x	1.17x	$32.54 Million
2012	19.10%	19.13%	0.86x	1.16x	$35.18 Million
2013	14.53%	15.79%	0.77x	1.20x	$21.38 Million
2014	15.80%	19.50%	0.67x	1.20x	$33.94 Million
2015	15.77%	20.70%	0.65x	1.17x	$41.25 Million
2016	12.54%	18.50%	0.61x	1.11x	$21.13 Million
2017	11.09%	16.88%	0.59x	1.11x	$10.57 Million
2018	13.20%	21.95%	0.55x	1.10x	$37.92 Million
2019	11.07%	19.76%	0.51x	1.09x	$14.96 Million
2020	6.79%	12.96%	0.47x	1.11x	$-48.34 Million
2021	8.57%	15.57%	0.49x	1.12x	$-24.95 Million
2022	10.30%	18.59%	0.49x	1.12x	$5.53 Million
2023	3.07%	7.83%	0.31x	1.27x	$-276.92 Million
2024	2.47%	4.09%	0.48x	1.26x	$-314.75 Million
2025	11.76%	18.30%	0.55x	1.16x	$80.58 Million

Industry Comparison

This section compares Globus Medical's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $2,555,245,291
Average return on equity (ROE) among peers: -57.95%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Globus Medical (GMED)	$4.57 Billion	23.86%	0.16x	$12.35 Billion
Abbott Laboratories (ABT)	$24.08 Billion	18.37%	0.83x	$155.56 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM)	$-95.88 Million	0.00%	0.00x	$21.60 Million
Aethlon Medical Inc (AEMD)	$9.29 Million	-84.45%	0.15x	$2.79 Million
Acutus Medical Inc (AFIB)	$105.73 Million	-116.68%	0.61x	$903.35K
Adapthealth Corp (AHCO)	$1.47 Billion	-46.29%	2.07x	$1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX)	$3.39 Million	-59.65%	0.38x	$15.99 Million
Allurion Technologies, Inc. (ALUR)	$-70.49 Million	0.00%	0.00x	$8.10 Million
Autonomix Medical, Inc. Common Stock (AMIX)	$644.00K	-309.01%	0.34x	$4.22 Million
Artivion Inc (AORT)	$30.20 Million	15.56%	0.78x	$1.73 Billion
Apyx Medical Inc (APYX)	$22.89 Million	2.69%	0.23x	$125.55 Million

About Globus Medical

NYSE:GMED USA Medical Devices

Market Cap

$12.35 Billion

Market Cap Rank

#1889 Global

#695 in USA

Share Price

$91.34

Change (1 day)

+1.29%

52-Week Range

$51.89 - $96.82

All Time High

$96.82